Clearlake and Charlesbank to inject $175m into distressed Symplr
Tuesday, September 22, 2026 · first reported by Private Equity Wire
Clearlake Capital and Charlesbank Capital are providing $175M preferred equity to healthcare software company Symplr as part of a restructuring to extend debt maturities; second-lien lenders adding $103.5M first-out second-lien facility.
- Firm
- Clearlake Capital Group
- Deal value
- $175M
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on Clearlake Capital Group
- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Lone Star buys €216m Dutch residential portfolio from Catella fundIPE Real Assets